This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

IPO Preview: Imperva, NewLink Genetics

Stocks in this article: IMPV NLNK IBM EMC AMGN CELG GRPN

NEW YORK ( TheStreet -- The IPO market is picking up again with Groupon's (GRPN) successful debut confirming there is investor appetite for the right offerings.

Renaissance Capital notes that 11 companies are looking to make the leap next week, and if that comes to pass it will be the busiest week since November 2007.

This week's slate of new issues includes Imperva (IMPV), a Redwood Shores, Calif.-based data security software provider that is seeking to raise $75 million. The company plans to sell 5 million shares at between $14 and $16 each, and is expected to debut on Wednesday.

Imperva targets small businesses with its on-demand web application security software with the idea that the product is cost-effective when compared to buying more hardware or hiring more IT people. The company's sales jumped $55 million for the nine months ended in September, up 45% from $38 million in the same period a year earlier. Despite the revenue jump though, Imperva's loss hasn't narrowed much at all, totaling $8.7 million for the latest nine-month period vs. a loss of $8.9 million in the same stretch the previous year.

Imperva mostly wants investors to look at its deferred revenue, which is the money it has invoiced but hasn't actually received yet. Deferred revenue, which is based on maintenance and support contracts, sat at $19.1 million for the nine months ended Sept. 30, up 39% from its 2010 total $13.7 million, according to the company's latest S-1 filing with the Securities and Exchange Commission.

If investors are looking at Imperva's products as a gauge of whether to buy the new stock, the IPO may be a bit of a tough sell. As the company states in its filing, "We have limited historic financial data, and we operate in a rapidly evolving market, and as such, any predictions about our future revenue and expenses may not be as accurate as they would be if we had a longer operating history or operated in a more predictable market."

Hacker fear though is driving the data security market, which is expected to grow to $38 billion in 2014 from $27 billion in 2010. As of March, Imperva has three issued patents and seven pending patents, which isn't considered to be a large number when compared to its competition, which includes IBM (symbol) and EMC (symbol). The Imperva deal is rumored to be oversubscribed, and Francis Gaskins, IPO Desktop's president, believes investors should stay on the sidelines.

"Unless they have a big uptick from here on, it looks like it's hard to get to cash flow break even for them," said Gaskins.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs